Reporting guidelines: optimal use in preventive medicine and public health.

[1]  Paolo Vineis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology--Molecular Epidemiology (STROBE-ME): an extension of the STROBE statement. , 2011, Mutagenesis.

[2]  S G E Marsh,et al.  A community standard for immunogenomic data reporting and analysis: proposal for a STrengthening the REporting of Immunogenomic Studies statement. , 2011, Tissue antigens.

[3]  J. Ioannidis,et al.  STrengthening the Reporting of OBservational studies in Epidemiology – Molecular Epidemiology (STROBE-ME): An Extension of the STROBE Statement , 2011, PLoS medicine.

[4]  J. Grimshaw,et al.  Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8 , 2011, BMJ : British Medical Journal.

[5]  Teresa To,et al.  Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. , 2011, Journal of clinical epidemiology.

[6]  J. Ioannidis,et al.  Strengthening the reporting of Genetic RIsk Prediction Studies: the GRIPS Statement. , 2011, Journal of clinical epidemiology.

[7]  David Moher,et al.  Reporting Guidelines for Survey Research: An Analysis of Published Guidance and Reporting Practices , 2011, PLoS medicine.

[8]  Iveta Simera,et al.  Describing reporting guidelines for health research: a systematic review. , 2011, Journal of clinical epidemiology.

[9]  Helen M Moore,et al.  Biospecimen reporting for improved study quality (BRISQ). , 2011, Journal of proteome research.

[10]  Stavros Petrou,et al.  Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[11]  Stavros Petrou,et al.  Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting , 2011, BMJ : British Medical Journal.

[12]  J. Gulcher,et al.  Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration , 2011, European Journal of Human Genetics.

[13]  J. Ioannidis,et al.  Strengthening the Reporting of Genetic Risk Prediction Studies: The GRIPS Statement , 2011, PLoS medicine.

[14]  Bret R. Shaw,et al.  Relevance of CONSORT reporting criteria for research on eHealth interventions. , 2010, Patient education and counseling.

[15]  Laura Smith,et al.  Best Practices in the Reporting of Participatory Action Research: Embracing Both the Forest and the Trees 1Ψ7 , 2010 .

[16]  Christina Niederstadt,et al.  Reporting and presenting information retrieval processes: the need for optimizing common practice in health technology assessment , 2010, International Journal of Technology Assessment in Health Care.

[17]  David M Kent,et al.  Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.

[18]  D. Moher,et al.  CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.

[19]  D. Moher,et al.  CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials , 2010, BMJ : British Medical Journal.

[20]  G. Antes.  The new CONSORT statement , 2010, BMJ : British Medical Journal.

[21]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[22]  David Atkins,et al.  Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[23]  Nicolette de Keizer,et al.  STARE-HI -Statement on Reporting of Evaluation Studies in Health Informatics , 2009, Yearbook of Medical Informatics.

[24]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[25]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[26]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[27]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, PLoS medicine.

[28]  Apa Publications,et al.  Reporting standards for research in psychology: why do we need them? What might they be? , 2008, The American psychologist.

[29]  D. Moher,et al.  Improving the reporting of pragmatic trials: an extension of the CONSORT statement , 2008, BMJ : British Medical Journal.

[30]  F Davidoff,et al.  Publication guidelines for quality improvement in health care: evolution of the SQUIRE project , 2008, Quality & Safety in Health Care.

[31]  D. Moher,et al.  Guidelines for Reporting Health Research: The EQUATOR Network's Survey of Guideline Authors , 2008, PLoS medicine.

[32]  D. Moher,et al.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. , 2008, Annals of internal medicine.

[33]  David Moher,et al.  Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. , 2008, Annals of internal medicine.

[34]  D. Moher,et al.  CONSORT for reporting randomised trials in journal and conference abstracts , 2008, The Lancet.

[35]  D. Moher,et al.  CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration , 2008, PLoS medicine.

[36]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[37]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[38]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[39]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. , 2007, Annals of internal medicine.

[40]  Ben S Cooper,et al.  The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. , 2007, The Lancet. Infectious diseases.

[41]  Julie Glanville,et al.  How to formulate research recommendations , 2006, BMJ : British Medical Journal.

[42]  Andrew Booth,et al.  "Brimful of STARLITE": toward standards for reporting literature searches. , 2006, Journal of the Medical Library Association : JMLA.

[43]  D. Moher,et al.  Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review , 2006, The Medical journal of Australia.

[44]  G. Ramirez,et al.  The promise and pitfalls of systematic reviews. , 2006, Annual review of public health.

[45]  S. Pocock,et al.  Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. , 2006, JAMA.

[46]  R. Willke,et al.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[47]  for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2005, Nature Clinical Practice Oncology.

[48]  David L Schriger,et al.  Suggestions for improving the reporting of clinical research: the role of narrative. , 2005, Annals of emergency medicine.

[49]  Andrea Manca,et al.  Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies , 2005, International Journal of Technology Assessment in Health Care.

[50]  Jill Hayden,et al.  Seven items were identified for inclusion when reporting a Bayesian analysis of a clinical study. , 2005, Journal of clinical epidemiology.

[51]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[52]  Paul A Estabrooks,et al.  RE-AIM: Evidence-based standards and a web resource to improve translation of research into practice , 2004, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[53]  Gunther Eysenbach,et al.  Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES) , 2004, Journal of medical Internet research.

[54]  N. Crepaz,et al.  Quality of study methods in individual- and group-level HIV intervention research: critical reporting elements. , 2004, AIDS education and prevention : official publication of the International Society for AIDS Education.

[55]  Michael J Campbell,et al.  Extending CONSORT to include cluster trials , 2004, BMJ : British Medical Journal.

[56]  Don C Des Jarlais,et al.  Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. , 2004, American journal of public health.

[57]  Evelyn P Whitlock,et al.  Evidence-based behavioral medicine: What is it and how do we achieve it? , 2003, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[58]  J. Sitzia,et al.  Good practice in the conduct and reporting of survey research. , 2003, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[59]  David Moher,et al.  The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].

[60]  David Moher,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. , 2003, Clinical chemistry.

[61]  S. Shiffman,et al.  Capturing momentary, self-report data: A proposal for reporting guidelines , 2002, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[62]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[63]  D. Moher,et al.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. , 2001, JAMA.

[64]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[65]  I. Olkin,et al.  Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement , 2000, Revista espanola de salud publica.

[66]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[67]  R. Glasgow,et al.  Evaluating the public health impact of health promotion interventions: the RE-AIM framework. , 1999, American journal of public health.

[68]  R. Elliott,et al.  Evolving guidelines for publication of qualitative research studies in psychology and related fields. , 1999, The British journal of clinical psychology.

[69]  F Moss,et al.  A new structure for quality improvement reports , 1999, Quality & safety in health care.

[70]  M Docherty,et al.  The case for structuring the discussion of scientific papers , 1999, BMJ.

[71]  G. Bonsel,et al.  Reporting Format for Economic Evaluation , 1998, PharmacoEconomics.

[72]  M C Weinstein,et al.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.

[73]  Milton C. Weinstein,et al.  Recommendations for Reporting Cost-effectiveness Analyses , 1996 .

[74]  D. Osoba,et al.  Guidelines for reporting results of quality of life assessments in clinical trials , 1996, Quality of Life Research.

[75]  I. Olkin,et al.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement. , 1996, JAMA.

[76]  M. Brown,et al.  Social Support During Pregnancy: A Unidimensional Or Multidimensional Construct? , 1986, Nursing research.

[77]  黄亚明（整理）,et al.  Equator network , 2012 .

[78]  A. Hrõbjartsson,et al.  Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed. , 2011, Journal of clinical epidemiology.

[79]  D. Altman,et al.  CONSORT statement: extension to cluster randomised trials , 2004, BMJ : British Medical Journal.

[80]  J Clark,et al.  How to peer review a qualitative manuscript , 2003 .

[81]  David R. Jones,et al.  Bayesian methods in health technology assessment: a review. , 2000, Health technology assessment.